Anavex Operating Income vs Quick Ratio Analysis
| AVXL Stock | USD 3.80 0.27 6.63% |
Anavex Life financial indicator trend analysis is way more than just evaluating Anavex Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anavex Life Sciences is a good investment. Please check the relationship between Anavex Life Operating Income and its Quick Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
Operating Income vs Quick Ratio
Operating Income vs Quick Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anavex Life Sciences Operating Income account and Quick Ratio. At this time, the significance of the direction appears to have pay attention.
The correlation between Anavex Life's Operating Income and Quick Ratio is -0.73. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Quick Ratio in the same time period over historical financial statements of Anavex Life Sciences, assuming nothing else is changed. The correlation between historical values of Anavex Life's Operating Income and Quick Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Anavex Life Sciences are associated (or correlated) with its Quick Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Quick Ratio has no effect on the direction of Operating Income i.e., Anavex Life's Operating Income and Quick Ratio go up and down completely randomly.
Correlation Coefficient | -0.73 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Operating Income
Operating Income is the amount of profit realized from Anavex Life Sciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Anavex Life Sciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Quick Ratio
A measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities.Most indicators from Anavex Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anavex Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. At this time, Anavex Life's Selling General Administrative is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 47.1 M this year, although Enterprise Value Over EBITDA will most likely fall to (7.39).
| 2021 | 2022 | 2023 | 2024 (projected) | Tax Provision | 358.5K | 7K | 8.1K | 7.6K | Interest Income | 947.0K | 6.5M | 7.5M | 7.9M |
Anavex Life fundamental ratios Correlations
Click cells to compare fundamentals
Anavex Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anavex Life fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
| Other Current Liab | 3.3M | 5.6M | 5.9M | 7.3M | 8.4M | 8.8M | |
| Total Current Liabilities | 7.3M | 10.8M | 10.2M | 12.5M | 14.4M | 15.1M | |
| Total Stockholder Equity | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 171.3M | |
| Net Debt | (29.2M) | (152.1M) | (149.2M) | (151.0M) | (135.9M) | (129.1M) | |
| Retained Earnings | (159.7M) | (197.6M) | (245.6M) | (293.1M) | (263.8M) | (250.6M) | |
| Cash | 29.2M | 152.1M | 149.2M | 151.0M | 173.7M | 182.4M | |
| Cash And Short Term Investments | 29.2M | 152.1M | 149.2M | 151.0M | 173.7M | 182.4M | |
| Common Stock Total Equity | 52.7K | 62.0K | 75.9K | 77.9K | 89.6K | 94.1K | |
| Common Stock Shares Outstanding | 58.2M | 69.8M | 76.9M | 79.8M | 91.8M | 96.3M | |
| Liabilities And Stockholders Equity | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
| Other Stockholder Equity | 186.9M | 348.3M | 388.0M | 434.8M | 500.1M | 525.1M | |
| Total Liab | 7.3M | 10.8M | 10.2M | 12.5M | 14.4M | 15.1M | |
| Total Current Assets | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
| Common Stock | 62.0K | 75.9K | 77.9K | 82K | 94.3K | 99.0K | |
| Accounts Payable | 4.0M | 4.7M | 3.8M | 4.3M | 5.0M | 5.2M | |
| Other Current Assets | 443.8K | 355.5K | 354.2K | 653K | 751.0K | 495.2K | |
| Non Current Liabilities Total | 3.3M | 5.6M | 4.3M | 7.3M | 8.4M | 8.8M | |
| Net Receivables | 4.8M | 9.1M | 3.2M | 2.7M | 3.1M | 2.1M | |
| Net Tangible Assets | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 171.3M | |
| Retained Earnings Total Equity | (133.4M) | (159.7M) | (197.6M) | (245.6M) | (221.0M) | (210.0M) | |
| Capital Surpluse | 153.6M | 186.9M | 348.3M | 388.0M | 446.2M | 468.5M | |
| Net Invested Capital | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 82.9M | |
| Net Working Capital | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 82.9M | |
| Capital Stock | 62.0K | 75.9K | 77.9K | 82K | 94.3K | 72.7K |
Pair Trading with Anavex Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anavex Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anavex Life will appreciate offsetting losses from the drop in the long position's value.Moving together with Anavex Stock
| 0.65 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Anavex Stock
| 0.71 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.63 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.52 | JSPRW | Jasper Therapeutics | PairCorr |
| 0.49 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.41 | ZNTL | Zentalis PharmaceuticalsL Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to Anavex Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anavex Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anavex Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anavex Life Sciences to buy it.
The correlation of Anavex Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anavex Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anavex Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anavex Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Anavex Stock analysis
When running Anavex Life's price analysis, check to measure Anavex Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anavex Life is operating at the current time. Most of Anavex Life's value examination focuses on studying past and present price action to predict the probability of Anavex Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anavex Life's price. Additionally, you may evaluate how the addition of Anavex Life to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Anavex Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Return On Assets (0.21) | Return On Equity (0.32) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.